P
PUR
vs
W
WIG20
Over the past 12 months, PUR has underperformed WIG20, delivering a return of -65% compared to the WIG20's +28% growth.
Stocks Performance
PUR vs WIG20
Performance By Year
PUR vs WIG20
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Pure Biologics SA
Glance View
Pure Biologics SA is a biopharmaceutical company, which engages in the research and development of innovative biological medicines and medical devices for use therapeutic and diagnostic tests. The company is headquartered in Wroclaw, Woj. Dolnoslaskie and currently employs 101 full-time employees. The company went IPO on 2018-12-11. The firm was founded in August 2010 and is located in Wroclaw, Poland.